For all these prescription medications, regardless of their form or specific brand, the principle remains constant: strict adherence to the prescribing clinicians instructions is paramount
Emerging next-generation options are Cagrisema, Retatrutide, and pipeline or investigational drugs such as VK2535, Amylin analogues, and mazdutide
Am J Sports Med 36:11711178 Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M (2015) Platelet-rich plasma: why intra-articular
The nearly painless self-injection process uses a unique self-injection device
So that's not appreciably different from what we're looking for this year in 2025
It is important to distinguish between what the MHRA has authorised and what is available on the NHS